CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief People Officer gave up 9,004 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 48,211 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 16,579 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 17,244 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 3,268 shares (to pay taxes)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at $2.22 ($22,200)
- 4 Grant or award Director acquired 5,958 shares (grant or award)
- 4 Grant or award Director acquired 7,513 shares (grant or award)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,644 shares (to pay taxes)
- 4 Grant or award Director acquired 5,349 shares (grant or award)
- 4 Grant or award Director acquired 6,740 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,775 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Medical Officer gave up 7,382 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,382 shares (to pay taxes)
- 4 Grant or award Director acquired 7,616 shares (grant or award)
- 4 Grant or award Director acquired 9,609 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 15 · 296 filings